Investor Relations
Mar 16, 2018
OPKO Health Announces Landmark Study Showing 4Kscore® Test is Strong Predictor of Prostate Cancer Mortality Published in European Urology MORE >>
Mar 01, 2018
OPKO Health Reports 2017 Fourth Quarter Business Highlights and Financial Results MORE >>
Feb 26, 2018
OPKO Health to Announce Fourth Quarter and Year End 2017 Financial Results on March 1, 2018 MORE >>
Jan 26, 2018
OPKO Health Announces Leadership Changes at BioReference Laboratories MORE >>

Code of Business Conduct and Ethics

Code of Business Conduct and Ethics Introduction

The Board has adopted a Code of Business Conduct and Ethics that applies to all of our directors, officers (including our Chief Executive Officer, our Chief Financial Officer, and our principal accounting officer), and employees.

Notice of Amendment:
On June 14, 2012, the Company's Board of Directors amended its Code of Business Conduct and Ethics to, among other things, further define various transactions which would constitute a conflict of interest, include provisions prohibiting usurpation of corporate opportunities, impose requirements of fair dealing and confidentiality, and clarify various reporting procedures and obligations for responding to government investigations and media or public inquiries.

Click here for OPKO's Code of Business Conduct and Ethics